General Information of Drug (ID: DMUPZFO)

Drug Name
Neihulizumab Drug Info
Indication
Disease Entry ICD 11 Status REF
Psoriatic arthritis FA21 Phase 2 [1]
Cross-matching ID
TTD Drug ID
DMUPZFO

Molecule-Related Drug Atlas

Molecule-Related Drug Atlas
Molecule Type:
DTT
Drug Status:
Clinical Trial Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
AbGn-168 DMT6H3J Allergy 4A80-4A85 Phase 2 [2]
RO-4905417 DMV319J Acute coronary syndrome BA41 Phase 2 [3]
SelK2 DMM6B6E Asthma CA23 Phase 2 [4]

Molecular Interaction Atlas of This Drug

Molecular Interaction Atlas

Drug Therapeutic Target (DTT)
DTT Name DTT ID UniProt ID MOA REF
P-selectin glycoprotein ligand 1 (SELPLG) TTS5K8U SELPL_HUMAN Inhibitor [1]

References

1 Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA)
2 Clinical pipeline report, company report or official report of Avarx.
3 WO patent application no. 2013,0144,05, Methods.
4 Clinical pipeline report, company report or official report of Tetherex Pharmaceuticals